# Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETH

> **NCT01212796** · — · UNKNOWN · sponsor: **Grupo Espanol de trasplantes hematopoyeticos y terapia celular** · enrollment: 350 (estimated)

## Conditions studied

- Allogeneic Stem Cell Transplantation

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT01212796
- **Lead sponsor:** Grupo Espanol de trasplantes hematopoyeticos y terapia celular
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2010-09
- **Primary completion:** 2011-03
- **Final completion:** 2011-06
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2010-10-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01212796

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01212796, "Allo After Allo Stem Cell Transplantation Following Relapse After Allogeneic Transplant in Haematological Malignancies: Retrospective Results of the GETH". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT01212796. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*